Literature DB >> 20660684

Genetic factors associated with elevated carbapenem resistance in KPC-producing Klebsiella pneumoniae.

Brandon Kitchel1, J Kamile Rasheed, Andrea Endimiani, Andrea M Hujer, Karen F Anderson, Robert A Bonomo, Jean B Patel.   

Abstract

In the United States, the most prevalent mechanism of carbapenem resistance among Enterobacteriaceae is the production of a Klebsiella pneumoniae carbapenemase (KPC). KPC-producing isolates often exhibit a range of carbapenem MICs. To better understand the factors that contribute to overall carbapenem resistance, we analyzed 27 KPC-producing K. pneumoniae isolates with different levels of carbapenem resistance, 11 with low-level (i.e., meropenem or imipenem MIC ≤ 4 μg/ml), 2 with intermediate-level (i.e., meropenem and imipenem MIC = 8 μg/ml), and 14 with high-level (i.e., imipenem or meropenem MIC ≥ 16 μg/ml) carbapenem resistance, that were received from throughout the United States. Among 14 isolates that exhibited high-level carbapenem resistance, Western blot analysis indicated that 10 produced an elevated amount of KPC. These isolates either contained an increased bla(KPC) gene copy number (n = 3) or had deletions directly upstream of the bla(KPC) gene (n = 7). Four additional isolates lacked elevated KPC production but had high-level carbapenem resistance. Porin sequencing analysis identified 22 isolates potentially lacking a functional OmpK35 and three isolates potentially lacking a functional OmpK36. The highest carbapenem MICs were found in two isolates that lacked both functioning porins and produced elevated amounts of KPC. The 11 isolates with low-level carbapenem resistance contained neither an upstream deletion nor increased bla(KPC) copy number. These results suggest that both bla(KPC) copy number and deletions in the upstream genetic environment affect the level of KPC production and may contribute to high-level carbapenem resistance in KPC-producing K. pneumoniae, particularly when coupled with OmpK36 porin loss.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20660684      PMCID: PMC2944623          DOI: 10.1128/AAC.00008-10

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  26 in total

1.  Expression of SHV-2 beta-lactamase and of reduced amounts of OmpK36 porin in Klebsiella pneumoniae results in increased resistance to cephalosporins and carbapenems.

Authors:  Brendan Crowley; Vicente J Benedí; Antonio Doménech-Sánchez
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

2.  Emergence of KPC-producing Pseudomonas aeruginosa in the United States.

Authors:  Laurent Poirel; Patrice Nordmann; Emilie Lagrutta; Timothy Cleary; L Silvia Munoz-Price
Journal:  Antimicrob Agents Chemother       Date:  2010-04-26       Impact factor: 5.191

3.  Substrate selectivity and a novel role in inhibitor discrimination by residue 237 in the KPC-2 beta-lactamase.

Authors:  Krisztina M Papp-Wallace; Magdalena Taracila; John M Hornick; Andrea M Hujer; Kristine M Hujer; Anne M Distler; Andrea Endimiani; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2010-04-26       Impact factor: 5.191

4.  Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae.

Authors:  H Yigit; A M Queenan; G J Anderson; A Domenech-Sanchez; J W Biddle; C D Steward; S Alberti; K Bush; F C Tenover
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

5.  Inhibitor resistance in the KPC-2 beta-lactamase, a preeminent property of this class A beta-lactamase.

Authors:  Krisztina M Papp-Wallace; Christopher R Bethel; Anne M Distler; Courtney Kasuboski; Magdalena Taracila; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2009-12-14       Impact factor: 5.191

6.  Ertapenem resistance among extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae isolates.

Authors:  Azita Leavitt; Inna Chmelnitsky; Raul Colodner; Itzhak Ofek; Yehuda Carmeli; Shiri Navon-Venezia
Journal:  J Clin Microbiol       Date:  2009-02-11       Impact factor: 5.948

7.  Emergence of blaKPC-containing Klebsiella pneumoniae in a long-term acute care hospital: a new challenge to our healthcare system.

Authors:  Andrea Endimiani; John M Depasquale; Sandra Forero; Federico Perez; Andrea M Hujer; Daneshia Roberts-Pollack; Paul D Fiorella; Nancy Pickens; Brandon Kitchel; Aida E Casiano-Colón; Fred C Tenover; Robert A Bonomo
Journal:  J Antimicrob Chemother       Date:  2009-09-09       Impact factor: 5.790

8.  Genetic organization of transposase regions surrounding blaKPC carbapenemase genes on plasmids from Klebsiella strains isolated in a New York City hospital.

Authors:  Thomas D Gootz; Mary Kay Lescoe; Fadia Dib-Hajj; Brian A Dougherty; Wen He; Phyllis Della-Latta; Richard C Huard
Journal:  Antimicrob Agents Chemother       Date:  2009-03-02       Impact factor: 5.191

9.  Contribution of OmpK36 to carbapenem susceptibility in KPC-producing Klebsiella pneumoniae.

Authors:  David Landman; Simona Bratu; John Quale
Journal:  J Med Microbiol       Date:  2009-06-25       Impact factor: 2.472

10.  Detection of KPC in Acinetobacter spp. in Puerto Rico.

Authors:  Iraida E Robledo; Edna E Aquino; María I Santé; Jorge L Santana; Diana M Otero; Carlos F León; Guillermo J Vázquez
Journal:  Antimicrob Agents Chemother       Date:  2009-12-28       Impact factor: 5.191

View more
  71 in total

1.  Molecular characteristics of KPC-producing Enterobacteriaceae at the early stage of their dissemination in Poland, 2008-2009.

Authors:  Anna Baraniak; Anna Grabowska; Radosław Izdebski; Janusz Fiett; Małgorzata Herda; Katarzyna Bojarska; Dorota Żabicka; Marta Kania-Pudło; Grazyna Młynarczyk; Zofia Żak-Puławska; Waleria Hryniewicz; Marek Gniadkowski
Journal:  Antimicrob Agents Chemother       Date:  2011-09-19       Impact factor: 5.191

2.  Role of ISKpn7 and deletions in blaKPC gene expression.

Authors:  Thierry Naas; Gaelle Cuzon; Ha-Vy Truong; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2012-06-25       Impact factor: 5.191

Review 3.  Intestinal Carriage of Carbapenemase-Producing Organisms: Current Status of Surveillance Methods.

Authors:  Roberto Viau; Karen M Frank; Michael R Jacobs; Brigid Wilson; Keith Kaye; Curtis J Donskey; Federico Perez; Andrea Endimiani; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2016-01       Impact factor: 26.132

4.  Comparison of a novel, rapid chromogenic biochemical assay, the Carba NP test, with the modified Hodge test for detection of carbapenemase-producing Gram-negative bacilli.

Authors:  Shawn Vasoo; Scott A Cunningham; Peggy C Kohner; Patricia J Simner; Jayawant N Mandrekar; Karen Lolans; Mary K Hayden; Robin Patel
Journal:  J Clin Microbiol       Date:  2013-07-03       Impact factor: 5.948

5.  Evaluation of ceftazidime and NXL104 in two murine models of infection due to KPC-producing Klebsiella pneumoniae.

Authors:  Andrea Endimiani; Kristine M Hujer; Andrea M Hujer; Mark E Pulse; William J Weiss; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2010-11-01       Impact factor: 5.191

6.  High-performance method to detection of Klebsiella pneumoniae Carbapenemase in Enterobacterales by LC-MS/MS.

Authors:  Otávio A Lovison; Renata B Rau; Daiana Lima-Morales; Evellyn K Almeida; Marina N Crispim; Fabiano Barreto; Afonso L Barth; Andreza F Martins
Journal:  Braz J Microbiol       Date:  2020-01-27       Impact factor: 2.476

Review 7.  Clinical and laboratory considerations for the rapid detection of carbapenem-resistant Enterobacteriaceae.

Authors:  Ritu Banerjee; Romney Humphries
Journal:  Virulence       Date:  2016-05-11       Impact factor: 5.882

8.  Global Dissemination of blaKPC into Bacterial Species beyond Klebsiella pneumoniae and In Vitro Susceptibility to Ceftazidime-Avibactam and Aztreonam-Avibactam.

Authors:  Krystyna M Kazmierczak; Douglas J Biedenbach; Meredith Hackel; Sharon Rabine; Boudewijn L M de Jonge; Samuel K Bouchillon; Daniel F Sahm; Patricia A Bradford
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

9.  Expansion and evolution of a virulent, extensively drug-resistant (polymyxin B-resistant), QnrS1-, CTX-M-2-, and KPC-2-producing Klebsiella pneumoniae ST11 international high-risk clone.

Authors:  Leonardo Neves Andrade; Lúcia Vitali; Gilberto Gambero Gaspar; Fernando Bellissimo-Rodrigues; Roberto Martinez; Ana Lúcia Costa Darini
Journal:  J Clin Microbiol       Date:  2014-05-07       Impact factor: 5.948

10.  Substitutions at position 105 in SHV family β-lactamases decrease catalytic efficiency and cause inhibitor resistance.

Authors:  Mei Li; Benjamin C Conklin; Magdalena A Taracila; Rebecca A Hutton; Marion J Skalweit
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.